Emerging therapeutic targets in myeloproliferative neoplasms and peripheral T-cell leukemia and lymphomas

Por Orlova, Anna, Wingelhofer, Bettina, Neubauer, Heidi A., Maurer, Barbara, Berger-Becvar, Angelika, Keserű, György Miklós, Gunning, Patrick T., Valent, Peter, Moriggl, Richard
Publicado no Expert Opin Ther Targets (2017)

Expansion of BCR/ABL1 (+) cells requires PAK2 but not PAK1

Por Edlinger, Leo, Berger‐Becvar, Angelika, Menzl, Ingeborg, Hoermann, Gregor, Greiner, Georg, Grundschober, Eva, Bago‐Horvath, Zsuzsanna, Al‐Zoughbi, Wael, Hoefler, Gerald, Brostjan, Christine, Gille, Lars, Moriggl, Richard, Spittler, Andreas, Sexl, Veronika, Hoelbl‐Kovacic, Andrea
Publicado no Br J Haematol (2017)

Pharmacologic inhibition of STAT5 in acute myeloid leukemia

Por Wingelhofer, Bettina, Maurer, Barbara, Heyes, Elizabeth C., Cumaraswamy, Abbarna A., Berger-Becvar, Angelika, de Araujo, Elvin D., Orlova, Anna, Freund, Patricia, Ruge, Frank, Park, Jisung, Tin, Gary, Ahmar, Siawash, Lardeau, Charles-Hugues, Sadovnik, Irina, Bajusz, Dávid, Keserű, György Miklós, Grebien, Florian, Kubicek, Stefan, Valent, Peter, Gunning, Patrick T., Moriggl, Richard
Publicado no Leukemia (2018)